IB-T101 Injection for Treatment of Patients with Advanced Clear Cell Renal Cell Carcinoma

Exclusion Criteria

• •1. CNS dysfunction with clinical significance. For example, seizures, cerebral ischemia/hemorrhage, dementia, cerebellar diseases, cerebral edema, reversible posterior encephalopathy syndrome, or any autoimmune disease involving the CNS.
• •2. Any form of primary and acquired immunodeficiency (such as severe combined immunodeficiency). Known human immunodeficiency virus (HIV) positive subjects
• •3. Have experienced myocardial infarction or unstable angina within the 6 months prior to screening
• •4. Pleural effusion requiring drainage for symptom management within 28 days prior to screening